Home › Kanser sa Ovary › District of Columbia › Washington
Pag-aaral pangklinika para sa Kanser sa Ovary sa Washington, DC
Isang pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Washington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Nagre-recruitPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Nagre-recruitPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Nagre-recruitPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Nagre-recruitPhase 2
- Holy Cross Hospital /ID# 275872, Silver Spring · 7 mi ang layo
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Nagre-recruitPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Nagre-recruitPhase 3
- MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
- Georgetown University Medical Center, Washington D.C.
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Nagre-recruitPhase 3
- Holy Cross Hospital, Silver Spring · 7 mi ang layo
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Nagre-recruitPhase 2
- Medstar Georgetown University Hospital, Washington D.C.
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Nagre-recruitPhase 3
- Holy Cross Hospital, Silver Spring · 7 mi ang layo
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Nagre-recruitPhase 1
- Normunity Investigational Site, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Nagre-recruitPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 2
- USA11-0, Bethesda · 7 mi ang layo
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Nagre-recruitPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Cancer Support Community Research & Training Institute, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi ang layo
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi ang layo
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Nagre-recruitPhase 1
- Holy Cross Hospital, Silver Spring · 7 mi ang layo
Pag-aaral para sa Kanser sa Ovary sa ibang lungsod
- Houston, TX89 pag-aaral
- New York City, NY69 pag-aaral
- Boston, MA61 pag-aaral
- Los Angeles, CA50 pag-aaral
- Nashville, TN49 pag-aaral
- Arlington, VA46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Columbus, OH39 pag-aaral
- St. Louis, MO38 pag-aaral
- Chicago, IL36 pag-aaral
- San Antonio, TX31 pag-aaral
- Cleveland, OH30 pag-aaral
Iba pang pag-aaral sa Washington
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer55 pag-aaral
- Kanser sa Suso46 pag-aaral
- Metastatic Cancer43 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser sa Prostate38 pag-aaral
- Obesity33 pag-aaral
- Colorectal Cancer29 pag-aaral
- Sakit sa Puso at Ugat ng Dugo28 pag-aaral
- Kanser sa Pantog26 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Lymphoma23 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.